A&O Shearman has advised the financing providers in connection with the acquisition financing for Lone Star Funds' agreement to acquire the Capsules & Health Ingredients division of Lonza Group AG.
An affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients division, a global leader in capsule design, manufacturing and encapsulation technology headquartered in Basel, Switzerland. The business operates globally across the Americas, Europe and Asia Pacific, comprising three segments: Hard Empty Capsules, Dosage Form Solutions and Health Ingredients. As part of the transaction, Lonza will retain a 40% equity position in the business.
Darren Hanwell debt finance partner at A&OShearman said: "We're thrilled to have advised on this deal and support on the delivery of the financing to help bring this transaction to fruition. Another great example of A&OShearman's ability to work seamlessly across products and borders to deliver for fantastic clients."
"Another great example of A&O Shearman's ability to work seamlessly across products and borders to deliver for fantastic clients." - Darren Hanwell, Partner
"This is a marquee transaction in the life sciences sector, and we are proud to have advised the financing providers." - Trevor Ingram, Partner
The A&O Shearman team was led by debt finance partnersDarren Hanwell and Robert Burt and high yield partners Trevor Ingram and Marc Plepelits. The team also included debt finance senior associates Kiddist Forsythe and Luke Newling and high yield senior associate Evangelia Andronikou, as well as associate Chantelle Fard and trainees Jessica Earlham and Agapi Gavriilidi.
The transaction is subject to customary closing conditions and approvals.